Journal
TRENDS IN IMMUNOLOGY
Volume 27, Issue 2, Pages 68-73Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.it.2005.12.006
Keywords
-
Categories
Ask authors/readers for more resources
Following the finding that indoleamine 2,3-dioxygenase (IDO), an enzyme expressed in the placenta, prevents rejection of allogeneic fetuses in mice, many studies have focused on the role of IDO in the regulation of the immune response. Most arguments for an immunoregulatory role of IDO in vivo are based on observations in mice. Here, we critically examine the arguments for and against a function of IDO-expressing human dendritic cells (DCs) and conclude that proof for an immunoregulatory role in vivo is still lacking.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available